Read news on drugmakers with our app.
Read more in the app
FTC challenges 'junk' patents held by 10 drugmakers, incl Novo Nordisk's Ozempic
Drugmakers Are Set to Pay 23andMe Millions to Access Consumer DNA
Drugmakers Are Set To Pay 23andMe Millions To Access Consumer DNA
